Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Feb. 27, 2003

Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation

Feb. 20, 2003

Merck designs new factor Xa and/or factor VIIa inhibitors

Feb. 20, 2003

Aventis claims novel factor VIIa inhibitors

Feb. 19, 2003

Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team

Feb. 17, 2003

Eptacog alfa in intracerebral hemorrhage

Feb. 13, 2003

Wyeth presents various series of PAI-1 inhibitors

Feb. 11, 2003

Design and synthesis of potent and selective direct thrombin inhibitors

Feb. 10, 2003

ZymoGenetics initiates rFXIII phase I trials, signs exclusive licensing agreement

Feb. 7, 2003

MIT details the rational design of LMWHs with improved properties

Feb. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...